FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135804917> ?p ?o ?g. }

• W2135804917 endingPage "848" @default.
• W2135804917 startingPage "843" @default.
• W2135804917 abstract "Background — Maternal anti-Ro and anti-La antibodies are associated with congenital heart block (CHB). Although endocardial fibroelastosis (EFE) has been described in isolated cases of autoantibody-mediated CHB, the natural history and pathogenesis of this disease are poorly understood. Methods and Results — We retrospectively reviewed the clinical history, echocardiography, and pathology of fetuses and children with EFE associated with CHB born to mothers positive for anti-Ro or anti-La antibodies at 5 centers. Thirteen patients were identified, 6 with a prenatal and 7 with a postnatal diagnosis. Six mothers were positive for anti-Ro and anti-La antibodies, and 7 were positive for anti-Ro antibodies only. Only 1 mother had autoimmune disease. Severe ventricular dysfunction was seen in all fetal and postnatal cases. Four fetal and 3 postnatal cases had EFE at initial presentation. However, 2 fetal and 4 postnatal cases developed EFE 6 to 12 weeks and 7 months to 5 years from CHB diagnosis, respectively, even despite ventricular pacing in 6 postnatal cases. Eleven (85%) either died (n=9) or underwent cardiac transplantation (n=2) secondary to the EFE. Pathologic assessment of the explanted heart, available in 10 cases, revealed moderate to severe EFE in 7 and mild EFE in 3 cases, predominantly involving the left ventricle. Immunohistochemistry in 4 cases (including 3 fetuses) demonstrated deposition of IgG in 4 and IgM in 3 and T-cell infiltrates in 3 cases, suggesting an immune response by the affected fetus or child. Conclusions — EFE occurs in the presence of autoantibody-mediated CHB despite adequate ventricular pacing. Autoantibody-associated EFE has a very high mortality rate, whether developing in fetal or postnatal life." @default.
• W2135804917 created "2016-06-24" @default.
• W2135804917 creator A5004161178 @default.
• W2135804917 creator A5014108350 @default.
• W2135804917 creator A5028750384 @default.
• W2135804917 creator A5047679905 @default.
• W2135804917 creator A5048058842 @default.
• W2135804917 creator A5062363011 @default.
• W2135804917 creator A5062368620 @default.
• W2135804917 creator A5069604831 @default.
• W2135804917 creator A5073174793 @default.
• W2135804917 creator A5077579966 @default.
• W2135804917 creator A5088100655 @default.
• W2135804917 creator A5089898578 @default.
• W2135804917 date "2002-02-19" @default.
• W2135804917 modified "2023-10-13" @default.
• W2135804917 title "Maternal Anti-Ro and Anti-La Antibody–Associated Endocardial Fibroelastosis" @default.
• W2135804917 cites W1970757660 @default.
• W2135804917 cites W1999340815 @default.
• W2135804917 cites W2011842744 @default.
• W2135804917 cites W2036248349 @default.
• W2135804917 cites W2045397476 @default.
• W2135804917 cites W2053652702 @default.
• W2135804917 cites W2055248529 @default.
• W2135804917 cites W2057665180 @default.
• W2135804917 cites W2060112825 @default.
• W2135804917 cites W2064372096 @default.
• W2135804917 cites W2070050292 @default.
• W2135804917 cites W2081438649 @default.
• W2135804917 cites W2091960642 @default.
• W2135804917 cites W2092135214 @default.
• W2135804917 cites W2092135885 @default.
• W2135804917 cites W2142562469 @default.
• W2135804917 cites W2170380223 @default.
• W2135804917 cites W4205182613 @default.
• W2135804917 cites W52149340 @default.
• W2135804917 doi "https://doi.org/10.1161/hc0702.104182" @default.
• W2135804917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11854125" @default.
• W2135804917 hasPublicationYear "2002" @default.
• W2135804917 type Work @default.
• W2135804917 sameAs 2135804917 @default.
• W2135804917 citedByCount "202" @default.
• W2135804917 countsByYear W21358049172012 @default.
• W2135804917 countsByYear W21358049172013 @default.
• W2135804917 countsByYear W21358049172014 @default.
• W2135804917 countsByYear W21358049172015 @default.
• W2135804917 countsByYear W21358049172016 @default.
• W2135804917 countsByYear W21358049172017 @default.
• W2135804917 countsByYear W21358049172018 @default.
• W2135804917 countsByYear W21358049172019 @default.
• W2135804917 countsByYear W21358049172020 @default.
• W2135804917 countsByYear W21358049172021 @default.
• W2135804917 countsByYear W21358049172022 @default.
• W2135804917 countsByYear W21358049172023 @default.
• W2135804917 crossrefType "journal-article" @default.
• W2135804917 hasAuthorship W2135804917A5004161178 @default.
• W2135804917 hasAuthorship W2135804917A5014108350 @default.
• W2135804917 hasAuthorship W2135804917A5028750384 @default.
• W2135804917 hasAuthorship W2135804917A5047679905 @default.
• W2135804917 hasAuthorship W2135804917A5048058842 @default.
• W2135804917 hasAuthorship W2135804917A5062363011 @default.
• W2135804917 hasAuthorship W2135804917A5062368620 @default.
• W2135804917 hasAuthorship W2135804917A5069604831 @default.
• W2135804917 hasAuthorship W2135804917A5073174793 @default.
• W2135804917 hasAuthorship W2135804917A5077579966 @default.
• W2135804917 hasAuthorship W2135804917A5088100655 @default.
• W2135804917 hasAuthorship W2135804917A5089898578 @default.
• W2135804917 hasBestOaLocation W21358049171 @default.
• W2135804917 hasConcept C126322002 @default.
• W2135804917 hasConcept C142724271 @default.
• W2135804917 hasConcept C159654299 @default.
• W2135804917 hasConcept C163764329 @default.
• W2135804917 hasConcept C172680121 @default.
• W2135804917 hasConcept C203014093 @default.
• W2135804917 hasConcept C2777162553 @default.
• W2135804917 hasConcept C2778258057 @default.
• W2135804917 hasConcept C2778921608 @default.
• W2135804917 hasConcept C2779234561 @default.
• W2135804917 hasConcept C2780074459 @default.
• W2135804917 hasConcept C2780942790 @default.
• W2135804917 hasConcept C2781278803 @default.
• W2135804917 hasConcept C54355233 @default.
• W2135804917 hasConcept C71924100 @default.
• W2135804917 hasConcept C86803240 @default.
• W2135804917 hasConceptScore W2135804917C126322002 @default.
• W2135804917 hasConceptScore W2135804917C142724271 @default.
• W2135804917 hasConceptScore W2135804917C159654299 @default.
• W2135804917 hasConceptScore W2135804917C163764329 @default.
• W2135804917 hasConceptScore W2135804917C172680121 @default.
• W2135804917 hasConceptScore W2135804917C203014093 @default.
• W2135804917 hasConceptScore W2135804917C2777162553 @default.
• W2135804917 hasConceptScore W2135804917C2778258057 @default.
• W2135804917 hasConceptScore W2135804917C2778921608 @default.
• W2135804917 hasConceptScore W2135804917C2779234561 @default.
• W2135804917 hasConceptScore W2135804917C2780074459 @default.
• W2135804917 hasConceptScore W2135804917C2780942790 @default.
• W2135804917 hasConceptScore W2135804917C2781278803 @default.
• W2135804917 hasConceptScore W2135804917C54355233 @default.

• next